Holen Sie sich die Stockscreener-App
8.27
0.24%
-0.02
Handel nachbörslich:
8.27
Biocryst Pharmaceuticals Inc Aktie (BCRX) Neueste Nachrichten
BioCryst at Cantor Global Healthcare Conference: Strategic Growth and Opportunities - Investing.com
What are BioCryst Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Momentum & Fast Entry Momentum Trade Alerts - khodrobank.com
Is BioCryst Pharmaceuticals Inc. forming a breakout patternInsider Selling & Long-Term Investment Growth Plans - khodrobank.com
Published on: 2025-09-04 04:25:22 - Newser
Is BioCryst Pharmaceuticals Inc. still worth holding after the dipGold Moves & Detailed Earnings Play Alerts - Newser
Is BioCryst Pharmaceuticals Inc. forming bullish engulfing patterns2025 Key Highlights & High Win Rate Trade Alerts - khodrobank.com
Can BioCryst Pharmaceuticals Inc. stock double in the next yearQuarterly Portfolio Review & Free Daily Entry Point Trade Alerts - khodrobank.com
Is a relief rally coming for BioCryst Pharmaceuticals Inc. holdersJuly 2025 Opening Moves & Fast Gaining Stock Reports - Newser
Best data tools to analyze BioCryst Pharmaceuticals Inc. stockWeekly Volume Report & Weekly High Conviction Ideas - Newser
Forecasting BioCryst Pharmaceuticals Inc. price range with options dataQuarterly Market Review & Expert Approved Momentum Trade Ideas - Newser
Understanding BioCryst Pharmaceuticals Inc.’s price movement2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
71,400 RSUs and 36,700 Stock Options: BioCryst's Latest Employee Compensation Package Details - Stock Titan
Applying Elliott Wave Theory to BioCryst Pharmaceuticals Inc.Gap Up & Daily Profit Maximizing Trade Tips - Newser
What to do if you’re stuck in BioCryst Pharmaceuticals Inc.Earnings Risk Report & Expert Approved Trade Ideas - Newser
BioCryst Pharmaceuticals Inc. stock prediction for this weekEarnings Growth Summary & AI Driven Stock Movement Reports - Newser
Can you recover from losses in BioCryst Pharmaceuticals Inc.Trade Risk Summary & Technical Pattern Alert System - Newser
How to read the order book for BioCryst Pharmaceuticals Inc.Trade Analysis Report & Daily Growth Stock Investment Tips - Newser
Is BioCryst Pharmaceuticals Inc. a defensive stockJuly 2025 Analyst Calls & Stock Portfolio Risk Management - khodrobank.com
Fibrodysplasia Ossificans Market to Experience Notable Growth in Forecast Span by 2032, DelveInsight Predicts | Ipsen, Regeneron Pharma, Biocryst - Barchart.com
Will BioCryst Pharmaceuticals Inc. benefit from rising consumer demandMarket Performance Report & Risk Controlled Stock Pick Alerts - khodrobank.com
How to build a custom watchlist for BioCryst Pharmaceuticals Inc.July 2025 Decliners & Expert Verified Stock Movement Alerts - Newser
Will BioCryst Pharmaceuticals Inc. see short term momentumTrade Signal Summary & Long-Term Safe Investment Plans - Newser
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 Revenue Soars 49%, Hits Record $163.4 Million on ORLADEYO Surge - Yahoo Finance
Is BioCryst Pharmaceuticals Inc. affected by consumer sentiment2025 Macro Impact & Low Volatility Stock Recommendations - khodrobank.com
Custom watchlist performance reports with BioCryst Pharmaceuticals Inc.2025 Support & Resistance & Daily Risk Controlled Trade Plans - Newser
Is BioCryst Pharmaceuticals Inc. backed by strong institutional buyingOptions Play & Daily Stock Momentum Reports - khodrobank.com
Is BioCryst Pharmaceuticals Inc.’s growth already priced in2025 Market Sentiment & Stock Market Timing Techniques - khodrobank.com
Will BioCryst Pharmaceuticals Inc. outperform its industry peersCEO Change & Weekly High Potential Alerts - khodrobank.com
BioCryst Pharmaceuticals Inc. Inches Above Key Support — Safe to Hold getLinesFromResByArray error: size == 0 - 강소기업뉴스
What is BioCryst Pharmaceuticals Inc.’s TAM (Total Addressable Market)Quarterly Market Summary & AI Driven Price Predictions - khodrobank.com
Published on: 2025-09-01 00:02:12 - Newser
What to do if you’re stuck in BioCryst Pharmaceuticals IncTrade Risk Summary & Long-Term Capital Growth Ideas - Newser
How to track smart money flows in BioCryst Pharmaceuticals Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser
Leading vs lagging indicators on BioCryst Pharmaceuticals Inc. performanceEarnings Recap Report & Daily Profit Focused Screening - Newser
Will BioCryst Pharmaceuticals Inc. stock benefit from AI tech trendsGDP Growth & Weekly Chart Analysis and Guides - Newser
Published on: 2025-08-31 13:57:41 - Newser
Chart based exit strategy for BioCryst Pharmaceuticals Inc.Market Risk Summary & Technical Confirmation Alerts - Newser
Published on: 2025-08-31 12:26:45 - Newser
Can technical indicators confirm BioCryst Pharmaceuticals Inc.’s reversal2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Applying Elliott Wave Theory to BioCryst Pharmaceuticals IncJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser
Is BioCryst Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - Newser
Is BioCryst Pharmaceuticals Inc. a candidate for recovery playMarket Movement Recap & Pattern Based Trade Signal System - Newser
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):